ClearBridge Investments’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $56.6M | Sell |
|
|||||
|
2024
Q3 | $68.2M | Sell |
|
|||||
|
2024
Q2 | $103M | Sell |
|
|||||
|
2024
Q1 | $194M | Sell |
|
|||||
|
2023
Q4 | $238M | Sell |
|
|||||
|
2023
Q3 | $220M | Sell |
|
|||||
|
2023
Q2 | $213M | Sell |
|
|||||
|
2023
Q1 | $193M | Sell |
|
|||||
|
2022
Q4 | $205M | Sell |
|
|||||
|
2022
Q3 | $255M | Sell |
|
|||||
|
2022
Q2 | $222M | Sell |
|
|||||
|
2022
Q1 | $240M | Buy |
|
|||||
|
2021
Q4 | $179M | Sell |
|
|||||
|
2021
Q3 | $246M | Buy |
|
|||||
|
2021
Q2 | $272M | Sell |
|
|||||
|
2021
Q1 | $333M | Buy |
|
|||||
|
2020
Q4 | $391M | Sell |
|
|||||
|
2020
Q3 | $345M | Sell |
|
|||||
|
2020
Q2 | $452M | Sell |
|
|||||
|
2020
Q1 | $380M | Buy |
|
|||||
|
2019
Q4 | $484M | Sell |
|
|||||
|
2019
Q3 | $557M | Sell |
|
|||||
|
2019
Q2 | $611M | Buy |
|
|||||
|
2019
Q1 | $771M | Sell |
|
|||||
|
2018
Q4 | $561M | Buy |
|
|||||
|
2018
Q3 | $528M | Sell |
|
|||||
|
2018
Q2 | $451M | Sell |
|
|||||
|
2018
Q1 | $481M | Sell |
|
|||||
|
2017
Q4 | $553M | Sell |
|
|||||
|
2017
Q3 | $580M | Sell |
|
|||||
|
2017
Q2 | $602M | Sell |
|
|||||
|
2017
Q1 | $477M | Sell |
|
|||||
|
2016
Q4 | $576M | Buy |
|
|||||
|
2016
Q3 | $397M | Sell |
|
|||||
|
2016
Q2 | $262M | Buy |
|
|||||
|
2016
Q1 | $451M | Buy |
|
|||||
|
2015
Q4 | $587M | Buy |
|
|||||
|
2015
Q3 | $379M | Sell |
|
|||||
|
2015
Q2 | $542M | Sell |
|
|||||
|
2015
Q1 | $610M | Buy |
|
|||||
|
2014
Q4 | $558M | Buy |
|
|||||
|
2014
Q3 | $349M | Buy |
|
|||||
|
2014
Q2 | $284M | Buy |
|
|||||
|
2014
Q1 | $317M | Buy |
|
|||||
|
2013
Q4 | $287M | Sell |
|
|||||
|
2013
Q3 | $271M | Buy |
|
|||||
|
2013
Q2 | $183M | Buy |
|